Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
- PMID: 23063829
- DOI: 10.1016/j.vaccine.2012.09.074
Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
Abstract
Adverse events following immunization (AEFI) reported to the national Vaccine Adverse Event Reporting System (VAERS) represent true causally related events, as well as events that are temporally, but not necessarily causally related to vaccine.
Objective: We sought to determine if the causal relationships between the vaccine and the AEFI reported to VAERS could be assessed through expert review.
Design: A stratified random sample of 100 VAERS reports received in 2004 contained 13 fatal cases, 19 cases with non-fatal disabilities, 39 other serious non-fatal cases and 29 non-serious cases. Experts knowledgeable about vaccines and clinical outcomes, reviewed each VAERS report and available medical records.
Main outcome measures: Modified World Health Organization criteria were used to classify the causal relationship between vaccines and AEFI as definite, probable, possible, unlikely or unrelated. Five independent reviewers evaluated each report. If they did not reach a majority agreement on causality after initial review, the report was discussed on a telephone conference to achieve agreement.
Results: 108 AEFIs were identified in the selected 100 VAERS reports. After initial review majority agreement was achieved for 83% of the AEFI and 17% required further discussion. In the end, only 3 (3%) of the AEFI were classified as definitely causally related to vaccine received. Of the remaining AEFI 22 (20%) were classified as probably and 22 (20%) were classified as possibly related to vaccine received; a majority (53%) were classified as either unlikely or unrelated to a vaccine received.
Conclusions: Using VAERS reports and additional documentation, causality could be assessed by expert review in the majority of VAERS reports. Assessment of VAERS reports identified that causality was thought to be probable or definite in less than one quarter of reports, and these were dominated by local reactions, allergic reactions, or symptoms known to be associated with the vaccine administered.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination.Pediatr Infect Dis J. 2013 Feb;32(2):163-8. doi: 10.1097/INF.0b013e318271b90a. Pediatr Infect Dis J. 2013. PMID: 23334340
-
Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.Vaccine. 2012 May 30;30 Suppl 2:B46-51. doi: 10.1016/j.vaccine.2011.12.112. Epub 2012 Jan 9. Vaccine. 2012. PMID: 22230584
-
Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.Vaccine. 2008 Feb 26;26(9):1166-72. doi: 10.1016/j.vaccine.2007.12.049. Epub 2008 Jan 22. Vaccine. 2008. PMID: 18255204 Review.
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. MMWR Surveill Summ. 2003. PMID: 12825543
-
Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):189-202. doi: 10.1002/pds.712. Pharmacoepidemiol Drug Saf. 2002. PMID: 12051118 Review.
Cited by
-
Lessons learned from annotation of VAERS reports on adverse events following influenza vaccination and related to Guillain-Barré syndrome.BMC Med Inform Decis Mak. 2024 Jan 5;23(Suppl 4):298. doi: 10.1186/s12911-023-02374-2. BMC Med Inform Decis Mak. 2024. PMID: 38183034 Free PMC article.
-
Acute Ischemic Stroke in the Context of SARS-CoV-2 Vaccination: A Systematic Review.Neuropsychiatr Dis Treat. 2022 Aug 30;18:1907-1916. doi: 10.2147/NDT.S374549. eCollection 2022. Neuropsychiatr Dis Treat. 2022. PMID: 36065388 Free PMC article. Review.
-
Usefulness of Vaccine Adverse Event Reporting System for Machine-Learning Based Vaccine Research: A Case Study for COVID-19 Vaccines.Int J Mol Sci. 2022 Jul 26;23(15):8235. doi: 10.3390/ijms23158235. Int J Mol Sci. 2022. PMID: 35897804 Free PMC article.
-
Can SARS-CoV-2 vaccine increase the risk of reactivation of Varicella zoster? A systematic review.J Cosmet Dermatol. 2021 Nov;20(11):3350-3361. doi: 10.1111/jocd.14521. J Cosmet Dermatol. 2021. PMID: 34719084 Free PMC article. Review.
-
Reactivation of Varicella Zoster Virus after Vaccination for SARS-CoV-2.Vaccines (Basel). 2021 Jun 1;9(6):572. doi: 10.3390/vaccines9060572. Vaccines (Basel). 2021. PMID: 34205861 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical